BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA
1809 results:

  • 1. Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a case-control study of Polish women in Poland and Polish immigrants in USA.
    Łukasiewicz-Śmietańska D; Godlewski D; Nowakowska E; Szpak A; Chabros E; Juszczyk G; Charzewska J; Rybaczyk-Pathak D
    PLoS One; 2024; 19(4):e0300061. PubMed ID: 38687739
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas.
    Akepogu J; Jakati S; Chaurasia S; Ramachandran C
    Exp Eye Res; 2024 Jun; 243():109901. PubMed ID: 38641197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.
    Zhou Q; Tu X; Hou X; Yu J; Zhao F; Huang J; Kloeber J; Olson A; Gao M; Luo K; Zhu S; Wu Z; Zhang Y; Sun C; Zeng X; Schoolmeester KJ; Weroha JS; Hu X; Jiang Y; Wang L; Mutter RW; Lou Z
    Drug Resist Updat; 2024 May; 74():101085. PubMed ID: 38636338
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of breast cancer-Associated Germline Pathogenic Variants in Mexico.
    Mesa-Chavez F; Chavarri-Guerra Y; Aguilar-Y-Mendez D; Becerril-Gaitan A; Vaca-Cartagena BF; Carrillo-Bedoya A; Santiesteban-González S; Aranda-Gutierrez A; Rodríguez-Faure A; Obregon-Leal D; Quintero-Beuló G; Rodriguez-Olivares JL; Miaja M; Weitzel JN; Villarreal-Garza C
    JCO Glob Oncol; 2024 Apr; 10():e2300417. PubMed ID: 38635940
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female breast cancer Risk.
    Wang Y; Sun Y; Tan M; Lin X; Tai P; Huang X; Jin Q; Yuan D; Xu T; He B
    DNA Cell Biol; 2024 May; 43(5):219-231. PubMed ID: 38634815
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency.
    Kulkarni A; Zhou J; Biyani N; Kathad U; Banerjee PP; Srivastava S; Prucsi Z; Solarczyk K; Bhatia K; Ewesuedo RB; Sharma P
    Cancer Res Commun; 2024 May; 4(5):1199-1210. PubMed ID: 38630886
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes.
    Singh K; Scalia J; Legare R; Quddus MR; Sung CJ
    Hum Pathol; 2024 Apr; 146():49-56. PubMed ID: 38608781
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
    Zhao B; Li J; Sinha S; Qin Z; Kou SH; Xiao F; Lei H; Chen T; Cao W; Ding X; Wang SM
    BMC Cancer; 2024 Apr; 24(1):415. PubMed ID: 38575974
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Out-of-Pocket Costs and Payments in Autologous and Implant-Based breast Reconstruction: A Nationwide Analysis.
    Oleru OO; Seyidova N; Taub PJ; Rohde CH
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S262-S266. PubMed ID: 38556686
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.
    Lally P; Kennedy F; Smith S; Beeken RJ; Buck C; Thomas C; Counsell N; Wyld L; Martin C; Williams S; Roberts A; Greenfield DM; Gath J; Potts HWW; Latimer N; Smith L; Fisher A
    Cancer Med; 2024 Mar; 13(6):e7124. PubMed ID: 38529687
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies.
    Godinez Paredes JM; Rodriguez I; Ren M; Orozco A; Ortiz J; Albanez A; Jones C; Nahleh Z; Barreda L; Garland L; Torres-Gonzalez E; Wu D; Luo W; Liu J; Argueta V; Orozco R; Gharzouzi E; Dean M
    Breast Cancer Res Treat; 2024 Jun; 205(3):567-577. PubMed ID: 38520597
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.
    Augustinsson A; Loman N; Ehrencrona H
    Breast Cancer Res Treat; 2024 Jun; 205(3):599-607. PubMed ID: 38491334
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate cancer Demonstrating "BRCAness" Genotype (ROAR).
    Sahu KK; Li H; Mathew Thomas V; Benson M; Boucher K; Gupta S; Kohli M; Swami U; Agarwal N; Maughan BL
    Oncologist; 2024 May; 29(5):450-e725. PubMed ID: 38452035
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of Telmisartan Alkylamine Derivatives as Potential Anticancer Agents.
    Schumacher TJ; Gardner ZS; McParlan MP; Omy T; Palle K; Rumbley J; Mereddy VR
    Anticancer Res; 2024 Mar; 44(3):911-919. PubMed ID: 38423633
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
    Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
    Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    Sun J; Frick KD; Liang H; Chow CM; Aronowitz S; Shi L
    PLoS One; 2024; 19(2):e0290105. PubMed ID: 38416784
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immediate prepectoral breast reconstruction in nipple-sparing mastectomy with Wise-pattern incision in large and ptotic breasts: Our experience and short-term results.
    Antoniazzi E; De Grazia A; Dell'Antonia F; Pasquali S; Burelli P; Rizzetto C; Berna G
    J Plast Reconstr Aesthet Surg; 2024 Apr; 91():154-163. PubMed ID: 38412604
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. 21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery.
    Xie SJ; Wang RJ; Wu SG; Zhang FX
    Breast; 2024 Apr; 74():103679. PubMed ID: 38367283
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic
    Tahara M; Kiyota N; Imai H; Takahashi S; Nishiyama A; Tamura S; Shimizu Y; Kadowaki S; Ito KI; Toyoshima M; Hirashima Y; Ueno S; Sugitani I
    Thyroid; 2024 Apr; 34(4):467-476. PubMed ID: 38343359
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 91.